Seth Benson

Nuclera has appointed Seth Benson as Chief Financial Officer

Nuclera, the biotechnology company accelerating protein expression and optimisation through its benchtop eProtein Discovery system, has announced that it has appointed Seth Benson as Chief Financial Officer.

Seth’s appointment comes after Nuclera strengthened its leadership team with three key appointments as the company continues to scale during this next phase of commercial development.

Bringing extensive financial expertise in building operational and financial infrastructure, Seth will be instrumental in guiding Nuclera’s next phase of commercial expansion across key global markets.

With over 20 years of leadership experience in finance, strategy and operations in the life sciences and healthcare sectors, Seth has a proven track record of scaling businesses, driving strategic growth, optimising operations and leading strategic financial initiatives.

Seth joins Nuclera from Vizgen, a company improving human health through spatial genomics. At Vizgen, he led the finance, operations and IT functions as CFO and guided the organisation through its acquisition of Ultivue, a spatial proteomics company.

Previously, as SVP Finance and Operations at Invaio Sciences, Seth managed a multinational finance team during early product commercialisation and fundraising.

Seth said: “I am delighted to join Nuclera, especially at such an exciting time for the company. Nuclera’s eProtein Discovery system addresses a critical bottleneck in protein production workflows, with the potential to significantly impact drug discovery.”